Skip to main content

Find Clinical Trials

Home
Conditions
ERBB2 Mutation-Related Tumors

Clinical trial condition

ERBB2 Mutation-Related Tumors

Explore clinical trials studying ERBB2 Mutation-Related Tumors. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

ERBB2 Mutation-Related Tumors trial results

Enrolling by Invitation

Integrated Genomics in Oncogene-driven NSCLC With Acquired Resistance

NCT07122882

Conditions: ALK Fusion-positive Solid or CNS Tumors, BRAF V600 Mutation, Central Nervous System Neoplasms, +15 more
Locations: Chang Gung Memorial Hospital Linkou Branch Taoyuan, Taiwan

View Trial Details

Not Yet Recruiting

RC48 Combined With EGFR or HER2 TKI for Locally Advanced or Metastatic NSCLC Patients With HER2 Alterations

NCT06185400

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: Not specified

View Trial Details